3-OH-Kynurenamine dihydroiodide is an aryl hydrocarbon receptor (AhR) agonist that modulates immune responses; it upregulates the expression of Ido1 and Tgfb1, ameliorating skin inflammation in a murine psoriasis model and renal injury in a murine nephrotoxic lupus model.